Beti-Cel, a Gene Therapy for Beta-Thalassemia, Gets FDA Panel Support
Beti-cel is an investigational one-time gene therapy that works by adding functional copies of a modified form of the beta-globin gene into a patient’s own hematopoietic stem cells.